Schedule 13G ownership disclosure

QUINCE THERAPEUTICS INC

Security class unavailable · CUSIP: 22053A107

Event date: 2023-07-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.0400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001567619-23-006604
Form type
SC 13G
Filer
BML Investment Partners, L.P.
CIK
CIK 1373604
Filed
Jul 17, 2023
Reporting period
Jul 06, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub